HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic vaccine against IL-1β improved glucose control in a mouse model of type 2 diabetes.

AbstractAIMS:
Inflammation is strongly associated with the mechanism of β-cell failure in type 2 diabetes mellitus (T2DM). Blockade of the key proinflammatory cytokine IL-1β has been implicated as a promising therapeutic strategy for the prevention and treatment of type 2 diabetes. In this study, we developed an IL-1β-targeted therapeutic vaccine consisting of an IL-1β epitope peptide (A1β) and assessed its efficacy on a diabetic KK-Ay mouse model.
MAIN METHODS:
KK-Ay mice were immunized with A1β for three injections at a 2-week interval. The induced antibody titers, body weights and blood glucose levels were monitored every two weeks. Then the intraperitoneal glucose tolerance test and insulin tolerance test were performed. The β-cell mass, β-cell apoptosis and proliferation were evaluated by immunofluorescence. IL-1β gene expression in islets was also measured by quantitative RT-PCR.
KEY FINDINGS:
A1β immunization induced robust antibody responses, reduced body weight gain, improved glucose tolerance and insulin sensitivity in KK-Ay mice. Moreover, A1β restored β-cell mass, inhibited β-cell apoptosis, enhanced β-cell proliferation and downregulated IL-1β expression.
SIGNIFICANCE:
The novel IL-1β-targeted epitope vaccine has the therapeutic potential for T2DM.
AuthorsYue Zhang, Xiao-Lin Yu, Jun Zha, Li-Zhen Mao, Jia-Qian Chai, Rui-Tian Liu
JournalLife sciences (Life Sci) Vol. 192 Pg. 68-74 (Jan 01 2018) ISSN: 1879-0631 [Electronic] Netherlands
PMID29155303 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier Inc. All rights reserved.
Chemical References
  • Antibodies
  • Blood Glucose
  • Epitopes
  • Immunoglobulin G
  • Interleukin-1beta
  • Vaccines
Topics
  • Animals
  • Antibodies (analysis)
  • Apoptosis
  • Blood Glucose (metabolism)
  • Body Weight
  • Cell Proliferation
  • Diabetes Mellitus, Type 2 (genetics, metabolism, therapy)
  • Disease Models, Animal
  • Down-Regulation (genetics, immunology)
  • Epitopes (immunology)
  • Glucose Tolerance Test
  • Immunoglobulin G (analysis, biosynthesis)
  • Insulin Resistance
  • Insulin-Secreting Cells (metabolism)
  • Interleukin-1beta (immunology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Vaccines (immunology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: